ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/10/2026
Back to search
Official data from USPTO
AVEKTRUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
06/11/2026
Trademark type
Word
Nice classes
5
Filing date
10/07/2022
Registration date
04/30/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/30/2024
Last transaction
06/11/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
13
Owner location
CAMANA BAY, US
Examiner
JOINER, KATINA JACKSON
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
D. L. (pessoa física)
Kalvista Pharmaceuticals Limited
Representatives
Stacy L. Wu Cast Legal Studio PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of angioedema; Pharmaceutical preparations for the treatment of hereditary angioedema; Pharmaceutical preparations for the treatment of bradykinin mediated inflammatory disorders; Pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; Pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders; Pharmaceutical preparations for containing sebetralstat; Pharmaceutical preparations for containing feniralstat(Based on 44(d) Priority Application) Pharmaceutical preparations for the treatment of angioedema; Pharmaceutical preparations for the treatment of hereditary angioedema; Pharmaceutical preparations for the treatment of bradykinin mediated inflammatory disorders; Pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; Pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders; Pharmaceutical preparations for containing sebetralstat for the treatment of angioedemahereditary angioedemabradykinin mediated inflammatory disordersplasma kallikrein or factor XIIa mediated diseases or disordersdiseases and disorders mediated by the contact activation system
Publications
History of USPTO decisions and trademark events.
28 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/06/2026
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10/09/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/09/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/09/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/09/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/09/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/09/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/30/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/30/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/13/2024
PUBO
PUBLISHED FOR OPPOSITION
02/13/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/24/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/11/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
01/11/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/11/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
01/11/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/11/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/26/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/26/2023
ALIE
ASSIGNED TO LIE
12/26/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/31/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/12/2023
GNRT
NON-FINAL ACTION E-MAILED
05/12/2023
CNRT
NON-FINAL ACTION WRITTEN
05/12/2023
DOCK
ASSIGNED TO EXAMINER
05/05/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/24/2022
NWAP
NEW APPLICATION ENTERED
10/11/2022
Continuous trademark protection
Get notified about every new filing that threatens AVEKTRUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.